Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results – YTD’26 Net Income of $25.6M, +85.9% from YTD’25
– Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics
– Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
– Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine-month periods ended September 30, 2026.
(unaudited; $ in Three millions, Months except per Ended share September amounts) 30, 2026 2025 Change (%)* ────────────────────────────────────────────────────────────────────────────── Total $ 657.0 $ 580.4 13.2 % revenue Gross $ 134.7 $ 122.6 9.9 % profit Operating $ 20.5 $ 14.4 42.6 % income Net $ 13.5 $ 6.9 96.6 % incomea Non-GAAP adjusted $ 28.0 $ 24.1 16.3 % net incomeb Net income $ 0.10 $ 0.05 100.0 % per share Non-GAAP adjusted $ 0.21 $ 0.19 10.5 % net income per shareb *Any slight variations in totals are due to rounding. a.Net income for the three months ended September 30, 2026, included $14.0 million in non-cash stock compensat… expense. Net income for the three months ended September 30, 2025 included $19.0 million in non-cash stock compensat… expense. b.Reconci… of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.
Three Months Ended September 30, (unaudit… $ in 2026 2025 Change (%) millions) Implemen… 5,893 5,250 12.2 % Providers Value-Ba… Care 1,676,000 1,406,000 19.2 % Attribut… Lives Practice $ 1,028.8 $ 940.4 9.4 % Collecti… Care $ 138.1 $ 125.2 10.3 % Margin Platform $ 73.9 $ 70.6 4.8 % Contribu… Adjusted $ 40.6 $ 38.2 6.3 % EBITDA c.Reconc… of Care Margin, Platform Contribu… Adjusted EBITDA and other non-GAAP financial measures are presented in tables near the end of this press release.
For the ($ in Nine millions, Months except per Ended share September amounts) 30, 2026 2025 Change (%) ────────────────────────────────────────────────────────────────────────────── Total $ 1,893.4 $ 1,581.7 19.7 % revenue Gross $ 389.3 $ 339.0 14.8 % profit Operating $ 39.7 $ 23.0 73.1 % income Net $ 25.6 $ 13.8 85.9 % incomea Non-GAAP adjusted net $ 77.6 $ 65.3 18.9 % incomeb d e Net income $ 0.19 $ 0.11 72.7 % per share Non-GAAP adjusted net income $ 0.59 $ 0.51 15.7 % per shareb d e a.Net income for the nine months ended September 30, 2026 included $55.3 million in non-cash stock compensa… expense. Net income for the nine months ended September 30, 2025 included $55.6 million in non-cash stock compensa… expense. b.Reconc… of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.
Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
This week, the Company announced the acquisition of American Choice Healthcare MSSP, LLC, a wholly-owned subsidiary of Cano Health. This Accountable Care Organization (ACO) will care for more than 36,000 attributed lives in the Medicare Shared Savings Program (MSSP), increasing VBC attributed lives in ten existing Privia states and adding lives in three new states, starting January 1, 2027.
Privia Health paid approximately $36 million at closing using its balance sheet cash. The transaction is expected to have minimal impact on all key metrics in 2026 and positively contribute to Attributed Lives and Adjusted EBITDA in 2027.
Privia Health has agreed to end its partnership with Surgery Partners in Montana effective January 2027. The Company supports 69 providers and generated approximately $23 million in annual Practice Collections in Montana. This is expected to have no material impact on Adjusted EBITDA in 2027.
Privia Health's balance sheet at September 30, 2026, included cash and cash equivalents of $446.3 million and no debt. The Company’s cash balance does not reflect the acquisition of American Choice Healthcare MSSP, LLC at the end of October 2026. We expect to end this year with at least $520 million in cash and cash equivalents, including the American Choice Healthcare transaction and assuming the 2025 MSSP cash settlement and related provider disbursements occur before year end based on current accruals. 2
• Expect approximately 70% of Adjusted EBITDA to convert to free cash flow in full-year 2026, including the American Choice Healthcare transaction and assuming the 2025 MSSP cash settlement and related provider disbursements occur before year end based on current accruals • Guidance does not assume any new business development activity
d. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of Gross Profit, Operating Income and Net Income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
e. See “Key Metrics and Non-GAAP Financial Measures” for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share.
f. Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly press releases.
The Company will host a conference call on November 5, 2026, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and- events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. Go to https://register-conf.media- server.com/register/BI3e1a918b115e49a7b2ba6510d843a3c5 in order to pre-register and obtain your dial-in number and passcode to join the live conference call.
This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at ir.priviahealth.com .
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical 3 groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize ~1,400 physician practices, improve the patient experience for 6.3+ million patients, and reward 5,800+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.
The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non- GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.
The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.
The financial results in this press release reflect preliminary, unaudited results, which are not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC”). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things, our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.
Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or 4 shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
Contact: Robert Borchert SVP, Investor & Corporate Communications [email protected] 817.783.4841
September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── Assets -unaudited Current assets: Cash and cash $ 446,283 $ 479,685 equivalents Accounts 623,582 400,902 receivable Prepaid expenses and other current 29,693 30,414 assets Total current 1,099,558 911,001 assets Non-current assets: Property and 1,019 504 equipment, net Right-of-use 7,531 8,794 assets Intangible assets, 215,292 215,919 net Goodwill 215,789 209,842 Deferred tax asset — 2,274 Other non-current 24,528 21,044 assets Total non-current 464,159 458,377 assets Total assets $ 1,563,717 $ 1,369,378 Liabilities and stockholders’ equity Current liabilities: Accounts payable and accrued $ 99,753 $ 96,804 expenses Provider liability 572,498 469,516 Operating lease liabilities, 2,107 2,200 current Total current 674,358 568,520 liabilities Non-current liabilities: Operating lease liabilities, 6,149 7,331 non-current Deferred tax 3,942 — liability Other non-current 6,354 2,584 liabilities Total non-current 16,445 9,915 liabilities Total liabilities 690,803 578,435 Commitments and contingencies Stockholders’ equity: Common stock 1,277 1,236 Additional paid-in 945,150 892,291 capital Accumulated -130,711 -156,310 deficit Total Privia Health Group, Inc. 815,716 737,217 stockholders’ equity Non-controlling 57,198 53,726 interest Total stockholders’ 872,914 790,943 equity Total liabilities and stockholders’ $ 1,563,717 $ 1,369,378 equity
For the Nine Months Cash flows from Ended September 30, operating activities 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 28,038 $ 19,141 Adjustments to reconcile net income to net cash (used in) provided by operating activities: Depreciation 432 580 Amortization of 9,708 6,670 intangibles Stock-based 55,349 55,616 compensation Deferred income taxes, 3,888 9,337 net Changes in asset and liabilities: Accounts receivable, -221,800 -176,544 net Prepaid expenses and other current 721 -3,038 assets Other non-current assets and -1,806 2,345 right-of-use assets Accounts payable and 2,949 2,682 accrued expenses Provider liability 102,102 118,815 Operating lease -1,509 -1,187 liabilities Other long-term 2,500 1,487 liabilities Net cash (used in) provided by operating -19,428 35,904 activities Cash from investing activities Business acquisitions, net of cash -11,430 -89,058 acquired Other -1,128 -1,200 Net cash used in -12,558 -90,258 investing activities Cash flows from financing activities Proceeds from exercised stock 7,468 4,557 options Repurchase of non-controlling -11,444 — interest Proceeds from non-controlling 2,560 — interest Net cash (used in) provided by financing -1,416 4,557 activities Net decrease in cash and cash -33,402 -49,797 equivalents Cash and cash equivalents at 479,685 491,149 beginning of period Cash and cash equivalents at end of $ 446,283 $ 441,352 period Supplemental disclosure of cash flow information: Interest paid $ 288 $ 188 Income taxes paid $ 14,136 $ 5,771 Supplemental disclosure of non-cash operating activities: Lease liabilities obtained in exchange $ 234 $ 1,832 for right-of-use assets Contingent $ 1,270 $ — consideration payable
The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:
(Dollars in thousands) September 30, 2026 2025 ────────────────────────────────────────────────────────────────────────────── Balance, beginning of $ 78,989 $ 66,355 period Incurred health care costs: Current year 271,675 228,352 Prior years(j) -12,387 -9,349 Total claims incurred $ 259,288 $ 219,003 Claims paid: Current year -174,640 -159,911 Prior year -58,217 -49,013 Total claims paid $ -232,857 $ -208,924 Balance, end of period $ 105,420 $ 76,434 (j) During the nine months ended September 30, 2026 and 2025, the prior years’ incurred healthcare costs for unpaid medical claims reflect standard reconciliations that resulted in the reduction of liabilities and corresponding reduction in receivables. The net impact of these standard reconciliations were not material to the Company’s results of operations, including Net Income, non-GAAP Adjusted EBITDA or cash flows.
Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.
For the For Three the Months Nine Ended Months Septem… Ended 30, Septe… 30, (una… $ in 2026 2025 2026 2025 mill… Impl… Prov… (as of 5,893 5,250 5,893 5,250 end of peri… Attr… Lives (as of 1,676… 1,406,… 1,676,… 1,406… end of peri… Prac… $ 1,028… $ 940.4 $ 2,913.6 $ 2,601… Coll… (1)I… Prov… is defi… as the total of all serv… prof… at the end of a given peri… who are cred… and bill for medi… serv… in both Owned and Non-… Medi… Grou… duri… that peri… (2)A… Lives are defi… as any pati… that a payer deems attr… to Priv… to deli… care as part of a valu… care arra… thro… a prov… of prim… care or spec… serv… as of the end of a part… peri… (3)P… Coll… are defi… as the total coll… from all prac… in all mark… and all sour… of reim… that the Comp… rece… for deli… care and prov… Priv… Heal… plat… and asso… serv… Prac… Coll… diff… from reve… by incl… coll… from Non-… Medi… Grou… (k)A… slig… vari… in tota… are due to roun…
11 Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share (p)
Full text with the tables
Exhibit 99.1
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
– YTD’26 Net Income of $25.6M, +85.9% from YTD’25
– YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25
– Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics
– Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP
Business
– Exits Montana Partnership effective January 2027
ARLINGTON, VA – November 5, 2026
– Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for
the third quarter and nine-month periods ended September 30, 2026.
Third Quarter Performance
(unaudited;
$ in Three
millions, Months
except per Ended
share September
amounts) 30, 2026 2025 Change (%)*
──────────────────────────────────────────────────────────────────────────────
Total $ 657.0 $ 580.4 13.2 %
revenue
Gross $ 134.7 $ 122.6 9.9 %
profit
Operating $ 20.5 $ 14.4 42.6 %
income
Net $ 13.5 $ 6.9 96.6 %
incomea
Non-GAAP
adjusted $ 28.0 $ 24.1 16.3 %
net
incomeb
Net income $ 0.10 $ 0.05 100.0 %
per share
Non-GAAP
adjusted $ 0.21 $ 0.19 10.5 %
net income
per shareb
*Any
slight
variations
in totals
are due to
rounding.
a.Net
income for
the three
months
ended
September
30, 2026,
included
$14.0
million in
non-cash
stock
compensat…
expense.
Net income
for the
three
months
ended
September
30, 2025
included
$19.0
million in
non-cash
stock
compensat…
expense.
b.Reconci…
of
non-GAAP
adjusted
net income
and other
non-GAAP
financial
measures
are
presented
in tables
near the
end of
this press
release.
Key Operating and Non-GAAP Financial Metrics c
Three
Months
Ended
September
30,
(unaudit…
$ in 2026 2025 Change (%)
millions)
Implemen… 5,893 5,250 12.2 %
Providers
Value-Ba…
Care 1,676,000 1,406,000 19.2 %
Attribut…
Lives
Practice $ 1,028.8 $ 940.4 9.4 %
Collecti…
Care $ 138.1 $ 125.2 10.3 %
Margin
Platform $ 73.9 $ 70.6 4.8 %
Contribu…
Adjusted $ 40.6 $ 38.2 6.3 %
EBITDA
c.Reconc…
of Care
Margin,
Platform
Contribu…
Adjusted
EBITDA
and other
non-GAAP
financial
measures
are
presented
in tables
near the
end of
this
press
release.
1
Nine-Month Performance
For the
($ in Nine
millions, Months
except per Ended
share September
amounts) 30, 2026 2025 Change (%)
──────────────────────────────────────────────────────────────────────────────
Total $ 1,893.4 $ 1,581.7 19.7 %
revenue
Gross $ 389.3 $ 339.0 14.8 %
profit
Operating $ 39.7 $ 23.0 73.1 %
income
Net $ 25.6 $ 13.8 85.9 %
incomea
Non-GAAP
adjusted
net $ 77.6 $ 65.3 18.9 %
incomeb d
e
Net
income $ 0.19 $ 0.11 72.7 %
per share
Non-GAAP
adjusted
net
income $ 0.59 $ 0.51 15.7 %
per
shareb
d e
a.Net
income
for the
nine
months
ended
September
30, 2026
included
$55.3
million
in
non-cash
stock
compensa…
expense.
Net
income
for the
nine
months
ended
September
30, 2025
included
$55.6
million
in
non-cash
stock
compensa…
expense.
b.Reconc…
of
non-GAAP
adjusted
net
income
and other
non-GAAP
financial
measures
are
presented
in tables
near the
end of
this
press
release.
Key Operating and Non-GAAP Financial Metrics b d e
For the
Nine
Months
Ended
($ in September
millions) 30, 2026 2025 Change (%)
──────────────────────────────────────────────────────────────────────────────
Practice $ 2,913.6 $ 2,601.9 12.0 %
Collecti…
Care $ 399.0 $ 345.7 15.4 %
Marginb d
Platform
Contribu… $ 209.9 $ 179.8 16.8 %
d
Adjusted
EBITDAb d $ 114.7 $ 94.1 21.9 %
e
Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP
Business
This week, the Company announced the acquisition of American Choice Healthcare
MSSP, LLC, a wholly-owned subsidiary of Cano Health. This Accountable Care
Organization (ACO) will care for more than 36,000 attributed lives in the
Medicare Shared Savings Program (MSSP), increasing VBC attributed lives in ten
existing Privia states and adding lives in three new states, starting January 1,
2027.
Privia Health paid approximately $36 million at closing using its balance sheet
cash. The transaction is expected to have minimal impact on all key metrics in
2026 and positively contribute to Attributed Lives and Adjusted EBITDA in 2027.
Exits Montana Partnership effective January 2027
Privia Health has agreed to end its partnership with Surgery Partners in Montana
effective January 2027. The Company supports 69 providers and generated
approximately $23 million in annual Practice Collections in Montana. This is
expected to have no material impact on Adjusted EBITDA in 2027.
Capital Resources
Privia Health's balance sheet at September 30, 2026, included cash and cash
equivalents of $446.3 million and no debt. The Company’s cash balance does not
reflect the acquisition of American Choice Healthcare MSSP, LLC at the end of
October 2026. We expect to end this year with at least $520 million in cash and
cash equivalents, including the American Choice Healthcare transaction and
assuming the 2025 MSSP cash settlement and related provider disbursements occur
before year end based on current accruals.
2
Updated Full-Year 2026 Guidance
d e f g
Privia Health raised its full-year 2026 outlook as follows:
Ini… Upda…
FY FY
FY 2026 2026
2025 Gui… Guid…
at at
2.2… 11.5…
($
in Act… Low High
mi…
Im… 5,3… 5,9… 6,0… High
Pr… End
At… 1,6…
Li… 1,5… 1,5… 1,6… -
1,6…
$
Pr… $ 3,4… $ 3,650 $ 3,750 3,9…
Co… -
3,9…
$
GA… $ 2,1… $ 2,350 $ 2,450 2,5…
Re… -
2,5…
Ca… $
Ma… $ 462… $ 515 $ 530 535
e f -
540
Pl… $
Co… $ 234… $ 260 $ 270 280
e -
285
Ad… $
EB… $ 125… $ 145 $ 155 154
e f -
157
• Expect approximately 70% of Adjusted EBITDA to convert to free cash flow in
full-year 2026, including the American Choice Healthcare transaction and
assuming the 2025 MSSP cash settlement and related provider disbursements occur
before year end based on current accruals
• Guidance does not assume any new business development activity
• Guidance for Implemented Providers includes 69 providers in Montana
d. Management has not reconciled forward-looking non-GAAP measures to their most
directly comparable GAAP measures of Gross Profit, Operating Income and Net
Income. This is because the Company cannot predict with reasonable certainty and
without unreasonable efforts the ultimate outcome of certain GAAP components of
such reconciliations due to market-related assumptions that are not within our
control as well as certain legal or advisory costs, tax costs or other costs
that may arise. For these reasons, management is unable to assess the probable
significance of the unavailable information, which could materially impact the
amount of the future directly comparable GAAP measures.
e. See “Key Metrics and Non-GAAP Financial Measures” for more information as to
how the Company defines and calculates Implemented Providers, Attributed Lives,
Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA,
and for a reconciliation of the most comparable GAAP measures to Care Margin,
Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net
Income Per Share.
f. Certain non-recurring or non-cash and other expenses will be treated as an
add back in the reconciliation of Net Income to Adjusted EBITDA, and the
reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per
Share, the details of which can be found in the Reconciliation schedules near
the end of this and in future quarterly press releases.
g. Any slight variations in totals due to rounding.
Webcast and Conference Call Information
The Company will host a conference call on November 5, 2026, at 8:00 am ET to
discuss these results and management’s outlook for future financial and
operational performance. You can visit ir.priviahealth.com/news-and-
events/events-and-presentations to listen to the call via live webcast. The
webcast will be archived and available for replay for on-demand listening
shortly after the completion of the call under the same link. Go to
https://register-conf.media-
server.com/register/BI3e1a918b115e49a7b2ba6510d843a3c5 in order to pre-register
and obtain your dial-in number and passcode to join the live conference call.
This news release and the financial statements contained herein, and the slide
presentation for the webcast, are also available on the Privia Health Investor
Relations website at ir.priviahealth.com .
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the
United States with a presence in 25 states and the District of Columbia. Privia
builds scaled provider networks with primary-care centric medical
3
groups, risk-bearing entities, a physician-led governance structure, and the
Privia Platform comprising an extensive suite of technology and service
solutions. Privia collaborates with medical groups, health plans and health
systems to optimize ~1,400 physician practices, improve the patient experience
for 6.3+ million patients, and reward 5,800+ physicians and advanced
practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes,
lower costs, and improve the health of communities and the well-being of
providers. For more information, visit priviahealth.com.
Non-GAAP Financial Measures
The Company reports and discusses its operating results using financial measures
consistent with accounting principles generally accepted in the United States
("GAAP"). From time to time, in press releases, financial presentations,
earnings conference calls or otherwise, the Company may disclose certain non-
GAAP financial measures. The non-GAAP financial measures presented in this press
release should not be viewed as alternatives or substitutes for the Company's
reported GAAP results. A reconciliation to the most directly comparable GAAP
financial measure is set forth in the tables that accompany this release.
The Company believes that the non-GAAP financial measures presented in this
press release are relevant and provide useful information to the Company's
management, investors, and other interested parties about the Company's
operating performance because the measures allow them to understand and compare
the Company's actual and expected operating results during the prior, current
and future periods in a more consistent manner. The non-GAAP measures presented
in this press release may not be comparable to similarly titled measures used by
other companies. These non-GAAP financial measures are used in addition to and
in conjunction with results presented in accordance with GAAP and reflect an
additional way of viewing aspects of the Company's operations that, when viewed
with GAAP results and the accompanying reconciliations to corresponding GAAP
financial measures, provides a more complete understanding of the results of
operations and trends affecting the Company's business. These non-GAAP financial
measures should be considered as a supplement to, and not as a substitute for,
or superior to financial measures calculated in accordance with GAAP.
Safe Harbor Statement
The financial results in this press release reflect preliminary, unaudited
results, which are not final until the Company’s Form 10-Q is filed with the
Securities and Exchange Commission (“SEC”). This press release contains
"forward-looking statements" within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such statements relate to our current
expectations, projections and assumptions about our business, the economy and
future events or conditions. They do not relate strictly to historical or
current facts. Forward-looking statements can be identified by words such as
“aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,”
“forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,”
“potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,”
“would,” “could,” “should,” and variations of such terms and similar expressions
and references to guidance, although some forward-looking statements may be
expressed differently. In particular, these include statements relating to,
among other things, our future actions, business plans, objectives and
prospects; and our future operating or financial performance and projections,
including our full-year guidance for 2026. Factors or events that could cause
actual results to differ may emerge from time to time and are difficult to
predict. Should known or unknown risks or uncertainties materialize, or should
underlying assumptions prove inaccurate, actual results may differ materially
from past results and those anticipated, estimated or projected. We caution you
not to place undue reliance upon any of these forward-looking statements.
Factors related to these risks and uncertainties include, but are not limited
to: the heavily regulated industry in which we operate, and any failure by us or
our medical groups to comply with the extensive applicable healthcare laws and
government regulations; the complexity of the legal framework governing our
relationships with Medical Groups, some of which we do not own, and Privia
providers, and the impact of legal challenges or
4
shifting interpretations of applicable laws; the execution of our growth
strategy, which may not prove viable and we may not realize expected results;
difficulties timely implementing our proprietary end-to-end, cloud-based
technology solution for Privia physicians and new medical groups; the high level
of competition in our industry; challenges in successfully establishing a
presence in new geographic markets; the impact of failures by or service
disruptions at key third-party vendors, such as our primary electronic medical
record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by
governmental and third-party payers, changes to payment terms or challenges
negotiating and retaining favorable contracts with private third-party payers,
and changes impacting our patient population; the financial and operational
impact of our compliance with various complex and changing federal and state
privacy and security laws and regulations related to our use, disclosure, and
other processing of personal information and protected health information,
including the Health Insurance Portability and Accountability Act of 1996; the
impact of actual and potential security threats, cybersecurity incidents or
privacy or other forms of data breaches involving us, our vendors or other third
parties; the continued availability of qualified workforce, including staff at
our medical groups, and the continued upward pressure on compensation for such
workforce; and other risk factors described in our Annual Report on Form 10-K
for the year ended December 31, 2025 and the Company’s subsequent Quarterly
Reports on Form 10-Q. All information in this press release is as of the date of
the release, and the Company undertakes no duty to update this information
unless required by law.
Contact:
Robert Borchert
SVP, Investor & Corporate Communications
[email protected]
817.783.4841
5
Privia Health Group, Inc.
Condensed Consolidated Statements of Operations
(g)
(unaudited)
(in thousands, except share and per share data)
For the For the
Three Nine
Months Months
Ended Ended
Septem… Septem…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Reven… $ 656,960 $ 580,419 $ 1,893,… $ 1,581,6…
Opera…
expen…
Provi… 518,857 455,209 1,494,… 1,236,0…
expen…
Cost
of 69,666 61,440 207,443 185,884
platf…
Sales
and 9,941 6,960 26,077 20,687
marke…
Gener…
and 34,452 39,641 115,583 108,881
admin…
Depre…
and 3,503 2,766 10,140 7,250
amort…
Total
opera… 636,419 566,016 1,853,… 1,558,7…
expen…
Opera… 20,541 14,403 39,736 22,957
income
Other — — 3,310 —
income
Inter…
incom… 1,724 2,271 5,280 7,610
net
Income
before
provi… 22,265 16,674 48,326 30,567
for
income
taxes
Provi…
for 7,671 6,867 20,288 11,426
income
taxes
Net 14,594 9,807 28,038 19,141
income
Less:
Net
income
attri… 1,107 2,946 2,439 5,373
to
non-c…
inter…
Net
income
attri…
to $ 13,487 $ 6,861 $ 25,599 $ 13,768
Privia
Health
Group,
Inc.
Net
income
per
share
attri…
to
Privia $ 0.11 $ 0.06 $ 0.20 $ 0.11
Health
Group,
Inc.
stock…
–
basic
Net
income
per
share
attri…
to
Privia $ 0.10 $ 0.05 $ 0.19 $ 0.11
Health
Group,
Inc.
stock…
–
dilut…
Weigh…
avera…
common
shares 127,53… 122,768… 125,94… 121,840…
outst…
–
basic
Weigh…
avera…
common
shares 132,70… 128,776… 131,86… 128,392…
outst…
–
dilut…
(g) Any slight variations in totals due to rounding.
6
Privia Health Group, Inc.
Condensed Consolidated Balance Sheets
(h)
(in thousands)
September 30, 2026 December 31, 2025
──────────────────────────────────────────────────────────────────────────────
Assets -unaudited
Current assets:
Cash and cash $ 446,283 $ 479,685
equivalents
Accounts 623,582 400,902
receivable
Prepaid expenses
and other current 29,693 30,414
assets
Total current 1,099,558 911,001
assets
Non-current
assets:
Property and 1,019 504
equipment, net
Right-of-use 7,531 8,794
assets
Intangible assets, 215,292 215,919
net
Goodwill 215,789 209,842
Deferred tax asset — 2,274
Other non-current 24,528 21,044
assets
Total non-current 464,159 458,377
assets
Total assets $ 1,563,717 $ 1,369,378
Liabilities and
stockholders’
equity
Current
liabilities:
Accounts payable
and accrued $ 99,753 $ 96,804
expenses
Provider liability 572,498 469,516
Operating lease
liabilities, 2,107 2,200
current
Total current 674,358 568,520
liabilities
Non-current
liabilities:
Operating lease
liabilities, 6,149 7,331
non-current
Deferred tax 3,942 —
liability
Other non-current 6,354 2,584
liabilities
Total non-current 16,445 9,915
liabilities
Total liabilities 690,803 578,435
Commitments and
contingencies
Stockholders’
equity:
Common stock 1,277 1,236
Additional paid-in 945,150 892,291
capital
Accumulated -130,711 -156,310
deficit
Total Privia
Health Group, Inc. 815,716 737,217
stockholders’
equity
Non-controlling 57,198 53,726
interest
Total
stockholders’ 872,914 790,943
equity
Total liabilities
and stockholders’ $ 1,563,717 $ 1,369,378
equity
(h) Any slight variations in totals are due to rounding.
7
Privia Health Group, Inc.
Condensed Consolidated Statements of Cash Flows
(i)
(unaudited)
(in thousands)
For the Nine Months
Cash flows from Ended September 30,
operating activities 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 28,038 $ 19,141
Adjustments to
reconcile net income
to
net cash (used in)
provided by operating
activities:
Depreciation 432 580
Amortization of 9,708 6,670
intangibles
Stock-based 55,349 55,616
compensation
Deferred income taxes, 3,888 9,337
net
Changes in asset and
liabilities:
Accounts receivable, -221,800 -176,544
net
Prepaid expenses and
other current 721 -3,038
assets
Other non-current
assets and -1,806 2,345
right-of-use assets
Accounts payable and 2,949 2,682
accrued expenses
Provider liability 102,102 118,815
Operating lease -1,509 -1,187
liabilities
Other long-term 2,500 1,487
liabilities
Net cash (used in)
provided by operating -19,428 35,904
activities
Cash from investing
activities
Business acquisitions,
net of cash -11,430 -89,058
acquired
Other -1,128 -1,200
Net cash used in -12,558 -90,258
investing activities
Cash flows from
financing activities
Proceeds from
exercised stock 7,468 4,557
options
Repurchase of
non-controlling -11,444 —
interest
Proceeds from
non-controlling 2,560 —
interest
Net cash (used in)
provided by financing -1,416 4,557
activities
Net decrease in cash
and cash -33,402 -49,797
equivalents
Cash and cash
equivalents at 479,685 491,149
beginning
of period
Cash and cash
equivalents at end of $ 446,283 $ 441,352
period
Supplemental
disclosure of cash
flow
information:
Interest paid $ 288 $ 188
Income taxes paid $ 14,136 $ 5,771
Supplemental
disclosure of non-cash
operating activities:
Lease liabilities
obtained in exchange $ 234 $ 1,832
for right-of-use
assets
Contingent $ 1,270 $ —
consideration payable
(i) Any slight variations in totals are due to rounding.
8
Additional Financial Information
Revenues disaggregated by source:
For the For the
Three Nine
Months Months
(Doll… Ended Ended
in Septemb… Septem…
thous… 2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
FFS-p… $ 433,088 $ 352,604 $ 1,236,… $ 995,829
care
FFS-a… 34,738 33,616 99,363 100,986
servi…
Capit… 99,520 90,906 280,818 237,108
reven…
Shared 68,838 79,994 212,720 187,927
savin…
Care
manag… 19,394 20,992 57,994 53,113
fees
(PMPM)
Other 1,382 2,307 5,681 6,706
reven…
Total $ 656,960 $ 580,419 $ 1,893,… $ 1,581,6…
Reven…
The Company’s liabilities for unpaid medical claims under at-risk capitation
arrangements:
(Dollars in
thousands) September 30, 2026 2025
──────────────────────────────────────────────────────────────────────────────
Balance, beginning of $ 78,989 $ 66,355
period
Incurred health care
costs:
Current year 271,675 228,352
Prior years(j) -12,387 -9,349
Total claims incurred $ 259,288 $ 219,003
Claims paid:
Current year -174,640 -159,911
Prior year -58,217 -49,013
Total claims paid $ -232,857 $ -208,924
Balance, end of period $ 105,420 $ 76,434
(j) During the nine
months ended
September 30, 2026 and
2025, the prior
years’ incurred
healthcare costs for
unpaid medical claims
reflect standard
reconciliations that
resulted in the
reduction of
liabilities and
corresponding reduction
in receivables.
The net impact of these
standard
reconciliations were
not material to the
Company’s results of
operations,
including Net Income,
non-GAAP Adjusted
EBITDA or cash flows.
9
Key Metrics and Non-GAAP Financial Measures
Privia Health reviews a number of operating and financial metrics, including the
following key metrics and non-GAAP financial measures, to evaluate the Company’s
business, measure performance, identify trends affecting the Company’s business,
formulate business plans, and make strategic decisions.
Key Metrics
(k)
For the For
Three the
Months Nine
Ended Months
Septem… Ended
30, Septe…
30,
(una…
$ in 2026 2025 2026 2025
mill…
Impl…
Prov…
(as
of 5,893 5,250 5,893 5,250
end
of
peri…
Attr…
Lives
(as
of 1,676… 1,406,… 1,676,… 1,406…
end
of
peri…
Prac… $ 1,028… $ 940.4 $ 2,913.6 $ 2,601…
Coll…
(1)I…
Prov…
is
defi…
as
the
total
of
all
serv…
prof…
at
the
end
of a
given
peri…
who
are
cred…
and
bill
for
medi…
serv…
in
both
Owned
and
Non-…
Medi…
Grou…
duri…
that
peri…
(2)A…
Lives
are
defi…
as
any
pati…
that
a
payer
deems
attr…
to
Priv…
to
deli…
care
as
part
of a
valu…
care
arra…
thro…
a
prov…
of
prim…
care
or
spec…
serv…
as of
the
end
of a
part…
peri…
(3)P…
Coll…
are
defi…
as
the
total
coll…
from
all
prac…
in
all
mark…
and
all
sour…
of
reim…
that
the
Comp…
rece…
for
deli…
care
and
prov…
Priv…
Heal…
plat…
and
asso…
serv…
Prac…
Coll…
diff…
from
reve…
by
incl…
coll…
from
Non-…
Medi…
Grou…
(k)A…
slig…
vari…
in
tota…
are
due
to
roun…
Non-GAAP Financial Measures
(5)(l)
For For
the the
Three Nine
Mont… Months
Ended Ended
(un… Sept… Septe…
$ in 30, 30,
tho… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Care $ 138,… $ 125,… $ 398,… $ 345,6…
Mar…
Pla… $ 73,9… $ 70,5… $ 209,… $ 179,7…
Con…
Pla…
Con… 53.5% 56.3% 52.6% 52.0%
Mar…
Adj… $ 40,5… $ 38,1… $ 114,… $ 94,093
EBI…
Adj…
EBI… 29.4% 30.5% 28.8% 27.2%
Mar…
(5)…
add…
to
res…
rep…
in
acc…
with
GAA…
Pri…
Hea…
dis…
Care
Mar…
Pla…
Con…
Pla…
Con…
mar…
Adj…
EBI…
and
Adj…
EBI…
Mar…
whi…
are
non…
fin…
mea…
Each
are
def…
as
fol…
•Ca…
Mar…
is
Gro…
Pro…
exc…
amo…
of
int…
ass…
•Pl…
Con…
is
Gro…
Pro…
exc…
amo…
of
int…
ass…
less
Cost
of
pla…
and
exc…
sto…
com…
exp…
inc…
in
Cost
of
pla…
•Pl…
Con…
mar…
is
Pla…
Con…
div…
by
Care
Mar…
•Ad…
EBI…
is
net
inc…
bef…
int…
inc…
net,
pro…
for
inc…
tax…
net
inc…
att…
to
non…
int…
dep…
and
amo…
sto…
com…
emp…
tax…
on
equ…
ves…
sev…
cha…
con…
and
def…
con…
and
oth…
non…
exp…
•Ad…
EBI…
Mar…
is
Adj…
EBI…
div…
by
Care
Mar…
(l)…
sli…
var…
in
tot…
are
due
to
rou…
10
Reconciliation of Gross Profit to Care Margin
(m)
For For
the the
Three Nine
Mont… Mont…
Ended Ended
(un… Sept… Sept…
$ in 30, 30,
tho… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Rev… $ 656,… $ 580,4… $ 1,893… $ 1,58…
Pro… -518… -455,… -1,49… -1,2…
exp…
Amo…
of -3,3… -2,601 -9,708 -6,6…
int…
ass…
Gro… $ 134,… $ 122,6… $ 389,2… $ 338,…
Pro…
Amo…
of 3,362 2,601 9,708 6,670
int…
ass…
Care $ 138,… $ 125,2… $ 398,9… $ 345,…
Mar…
(m)…
sli…
var…
in
tot…
are
due
to
rou…
Reconciliation of Gross Profit to Platform Contribution (n)
For For
the the
Three Nine
Mont… Mont…
Ended Ended
(un… Sept… Sept…
$ in 30, 30,
tho… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Rev… $ 656,… $ 580,4… $ 1,893… $ 1,58…
Pro… -518… -455,… -1,49… -1,2…
exp…
Amo…
of -3,3… -2,601 -9,708 -6,6…
int…
ass…
Gro… $ 134,… $ 122,6… $ 389,2… $ 338,…
Pro…
Amo…
of 3,362 2,601 9,708 6,670
int…
ass…
Cost
of -69,… -61,4… -207,… -185…
pla…
Sto… 5,489 6,785 18,411 19,9…
com…
Pla… $ 73,9… $ 70,555 $ 209,9… $ 179,…
Con…
(n)…
sli…
var…
in
tot…
are
due
to
rou…
(6)…
rep…
sto…
com…
exp…
inc…
in
Cost
of
pla…
Reconciliation of Net Income to Adjusted EBITDA
(o)
For For
the the
Three Nine
Mont… Mont…
Ended Ended
(un… Sept… Sept…
$ in 30, 30,
tho… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 13,4… $ 6,861 $ 25,599 $ 13,7…
inc…
Net
inc…
att… 1,107 2,946 2,439 5,373
to
non…
int…
Pro…
for 7,671 6,867 20,288 11,4…
inc…
tax…
Int…
inc… -1,7… -2,271 -5,280 -7,6…
net
Dep…
and 3,503 2,766 10,140 7,250
amo…
Sto… 14,0… 18,977 55,349 55,6…
com…
Oth… — — -3,310 —
inc…
Oth… 2,518 2,041 9,486 8,270
exp…
Adj… $ 40,5… $ 38,187 $ 114,7… $ 94,0…
EBI…
(o)…
sli…
var…
in
tot…
are
due
to
rou…
(7)…
exp…
inc…
emp…
tax…
on
equ…
ves…
sev…
con…
and
def…
con…
and
oth…
non…
exp…
11
Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per
Share (p)
For For
the the
Three Nine
Mont… Mont…
Ended Ended
(un… Sept… Sept…
$ in 30, 30,
tho… 2026 2025… 2026 2025…
──────────────────────────────────────────────────────────────────────────────
Net $ 13,4… $ 6,861 $ 25,5… $ 13,7…
inc…
Sto… 14,0… 18,9… 55,3… 55,6…
com…
Int…
amo… 3,362 2,601 9,708 6,670
exp…
Oth… 2,518 2,041 9,486 8,270
exp…
Oth… — — -3,3… —
inc…
Tax
eff… -5,3… -6,3… -19,… -19,…
of
adj…
Adj…
net $ 28,0… $ 24,1… $ 77,5… $ 65,2…
inc…
Adj…
net
inc…
per
sha…
att…
to $ 0.22 $ 0.20 $ 0.62 $ 0.54
Pri…
Hea…
Gro…
Inc.
sto…
–
bas…
Adj…
net
inc…
per
sha…
att…
to $ 0.21 $ 0.19 $ 0.59 $ 0.51
Pri…
Hea…
Gro…
Inc.
sto…
–
dil…
Wei…
ave…
com…
sha… 127,… 122,… 125,… 121,…
out…
–
bas…
Wei…
ave…
com…
sha… 132,… 128,… 131,… 128,…
out…
–
dil…
(p)…
sli…
var…
in
tot…
due
to
rou…
(8)…
exp…
inc…
emp…
tax…
on
equ…
ves…
sev…
con…
and
def…
con…
and
oth…
non…
exp…
(9)…
Com…
uses
a
sta…
ble…
tax
rate
of
27%
on
the
adj…
bet…
Net
Inc…
and
Adj…
Net
Inc…
(10…
to
con…
with
cur…
year
pre…
12